Skip to main content
logo
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
6.09
-0.54 (-8.14%)
At close: Nov 4, 2026, 4:00 PM EST
6.18
+0.09 (1.48%)
After-hours: Nov 4, 2026, 6:12 PM EST

aTyr Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
---0.19-----0.24-0.35--10.39-----
Revenue Growth (YoY)
--------------------
Cost of Revenue
6.757.3210.8922.1315.3811.8112.2314.8113.9713.3612.7610.329.849.3814.919.879.148.95.965.14
Gross Profit
-6.75-7.32-10.89-21.94-15.38-11.81-12.23-14.81-13.97-13.13-12.76-9.97-9.84-9.38-4.52-9.87-9.14-8.9-5.96-5.14
Selling, General & Admin
4.134.123.914.814.933.963.593.343.343.513.22.653.723.413.433.633.453.482.692.59
Operating Expenses
4.134.123.914.814.933.963.593.343.343.513.22.653.723.413.433.633.453.482.692.59
Operating Income
-10.88-11.44-14.8-26.75-20.31-15.77-15.82-18.14-17.32-16.64-15.96-12.62-13.56-12.79-7.95-13.49-12.58-12.38-8.64-7.73
Other Non Operating Income (Expenses)
0.570.640.8310.780.890.850.881.011.151.21.271.220.840.430.250.160.220.080.06
EBT Excluding Unusual Items
-10.31-10.79-13.96-25.75-19.53-14.88-14.97-17.26-16.31-15.49-14.76-11.34-12.34-11.95-7.52-13.25-12.42-12.15-8.56-7.67
Pretax Income
-10.31-10.79-13.96-25.75-19.53-14.88-14.97-17.26-16.31-15.49-14.76-11.34-12.34-11.95-7.52-13.25-12.42-12.15-8.56-7.67
Earnings From Continuing Operations
-10.31-10.79-13.96-25.75-19.53-14.88-14.97-17.26-16.31-15.49-14.76-11.34-12.34-11.95-7.52-13.25-12.42-12.15-8.56-7.67
Minority Interest in Earnings
00000000--00000000000
Net Income
-10.31-10.79-13.96-25.74-19.53-14.88-14.97-17.26-16.31-15.49-14.76-11.34-12.34-11.95-7.52-13.24-12.42-12.15-8.56-7.67
Net Income to Common
-10.31-10.79-13.96-25.74-19.53-14.88-14.97-17.26-16.31-15.49-14.76-11.34-12.34-11.95-7.52-13.24-12.42-12.15-8.56-7.67
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
22222222221111111110
Shares Outstanding (Diluted)
22222222221111111110
Shares Change (YoY)
8.82%13.36%18.48%28.17%24.68%30.88%39.59%30.95%31.08%57.72%103.53%101.95%96.50%50.61%4.77%57.84%74.00%97.24%162.84%88.21%
EPS (Basic)
-4.20-4.40-5.70-10.60-8.67-6.88-7.24-9.11-9.02-9.38-9.96-7.84-8.95-11.41-10.33-18.48-17.70-17.47-12.32-16.89
EPS (Diluted)
-4.20-4.40-5.70-10.60-8.67-6.88-7.24-9.11-9.02-9.38-9.96-7.84-8.95-11.41-10.33-18.48-17.70-17.47-12.33-16.89
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-9.42-12.66-12.23-20.51-13.9-15.42-13.16-13.17-20.46-22.4-11.08-10.12-14.41-1.84-11.49-12.71-9.17-10.16-8.1-11.53
Free Cash Flow Per Share
-3.84-5.16-4.99-8.45-6.17-7.13-6.36-6.95-11.32-13.56-7.48-6.99-10.45-1.75-15.78-17.73-13.07-14.61-11.66-25.40
Gross Margin
---------------43.56%-----
Operating Margin
----14076.32%------7079.15%--3573.65%---76.55%-----
Profit Margin
----13549.47%------6591.91%--3212.47%---72.41%-----
Free Cash Flow Margin
----10796.32%------9530.64%--2865.72%---110.61%-----
EBITDA
-10.71-11.27-14.63-26.58-20.15-15.61-15.65-17.97-17.14-16.46-15.78-12.44-13.4-12.71-7.91-13.44-12.52-12.3-8.53-7.61
EBITDA Margin
---------------76.17%-----
D&A For EBITDA
0.170.160.170.170.170.170.180.180.180.180.180.180.160.080.040.050.060.080.110.12
EBIT
-10.88-11.44-14.8-26.75-20.31-15.77-15.82-18.14-17.32-16.64-15.96-12.62-13.56-12.79-7.95-13.49-12.58-12.38-8.64-7.73
EBIT Margin
---------------76.55%-----
Revenue as Reported
---0.19-----0.24-0.35--10.39-----
SEC Filings: 10-K · 10-Q